Grown Rogue International (GRUSF) Cost of Revenue (2011 - 2026)
Grown Rogue International (GRUSF) posted quarterly Cost of Revenue of $5.2 million for Q1 2026, up 37.28% year-over-year from $3.8 million in Q1 2025, and up 100.0% quarter-over-quarter from -$8358.1 billion in Q4 2025.
Grown Rogue International (GRUSF) Cost of Revenue (2011 - 2026) Analysis & Trends
Grown Rogue International's Cost of Revenue history runs 13 years deep, the most recent figure standing at $5.2 million for Q1 2026.
- In Q1 2026, Cost of Revenue rose 37.28% year-over-year to $5.2 million; the TTM figure through Mar 2026 stood at $5559524120.6 billion (up 32240692326909.07% YoY), while the FY2025 annual figure was $18.3 million, up 36.64% from the prior year.
- Cost of Revenue for Q1 2026 stood at $5.2 million, up from -$8358.1 billion in the prior quarter.
- The five-year high for Cost of Revenue was $5559530698.5 billion in Q2 2025, with the low at -$8358.1 billion in Q4 2025.
- The 5-year median for Cost of Revenue is $308641.0 (2023), against an average of $370634941.4 billion.
- Peak annual rise in Cost of Revenue reached 1.2751400541654466e+16% in 2025, while the deepest fall reached 62469968.47% in 2025.
- Grown Rogue International's Cost of Revenue stood at $1.4 million in 2022, then plunged by 93.72% to $89210.0 in 2023, then surged by 14897.59% to $13.4 million in 2024, then tumbled by 62469968.47% to -$8358.1 billion in 2025, then soared by 100.0% to $5.2 million in 2026.
- Business Quant data shows GRUSF's Cost of Revenue at $5.2 million in Q1 2026, -$8358.1 billion in Q4 2025, and $1780.1 billion in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.81 Bn | 42.84 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.29 Bn | 39.63 Bn | 2.15 Bn | 1.99 Bn |
| 3 | Zoetis | 31.59 Bn | 29.91 Bn | 1.05 Bn | 673.00 Mn |
| 4 | Takeda Pharmaceutical | 28.67 Bn | 22.88 Bn | 5.10 Bn | 2.55 Bn |
| 5 | United Therapeutics | 22.24 Bn | 19.58 Bn | 683.80 Mn | 99.50 Mn |
| 6 | Viatris | 18.79 Bn | 17.91 Bn | 1.46 Bn | 2.30 Bn |
| 7 | Neurocrine Biosciences | 15.71 Bn | 15.32 Bn | 935.80 Mn | 23.20 Mn |
| 8 | Elanco Animal Health | 12.09 Bn | 11.56 Bn | 798.00 Mn | 570.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | - |
| 10 | Grown Rogue International | 114.97 Mn | 109.89 Mn | 5.37 Mn | 5.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 5.90 Mn |
| Jun 30, 2026 | 5.90 Mn |
| Mar 31, 2026 | 5.20 Mn |
| Mar 31, 2026 | 5.20 Mn |
| Dec 31, 2025 | -8,358.06 Bn |
| Dec 31, 2025 | -8,358.06 Bn |
| Sep 30, 2025 | 1,780.12 Bn |
| Sep 30, 2025 | 1,780.12 Bn |
| Jun 30, 2025 | 5,559,530,698.51 Bn |
| Jun 30, 2025 | 5,559,530,698.51 Bn |
| Mar 31, 2025 | 3.79 Mn |
| Mar 31, 2025 | 3.79 Mn |
| Dec 31, 2024 | 13.38 Mn |
| Dec 31, 2024 | 13.38 Mn |
| Sep 30, 2024 | 34,430.05 |
| Sep 30, 2024 | 34,430.05 |
| Jun 30, 2024 | 43,599.37 |
| Jun 30, 2024 | 43,599.37 |
| Mar 31, 2024 | 100,069.00 |
| Mar 31, 2024 | 100,069.00 |